Latest Information Update: 19 Oct 2000
At a glance
- Originator Goedecke
- Class Antivirals
- Mechanism of Action Protein kinase C inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 19 Oct 2000 Discontinued-Unspecified phase in HIV infections treatment in Germany (Unknown route)
- 18 Jan 1996 No-Development-Reported for HIV infections treatment in Germany (Unknown route)